Citation 1: Castañeda O, Sotolongo V, Amor AM, et al. Characterization of a potassium channel toxin from the Caribbean Sea anemone Stichodactyla helianthus. Toxicon. 1995;33(5):603-13. Published 1995 May. doi:10.1016/0041-0101(95)00013-c
Citation 2: Pennington MW, Byrnes ME, Zaydenberg I, et al. Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone. Int J Pept Protein Res. 1995;46(5):354-8. Published 1995 Nov. doi:10.1111/j.1399-3011.1995.tb01068.x
Citation 3: Pennington MW, Mahnir VM, Krafte DS, et al. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain. Biochem Biophys Res Commun. 1996;219(3):696-701. Published 1996 Feb 27. doi:10.1006/bbrc.1996.0297
Citation 4: Rauer H, Pennington M, Cahalan M, et al. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J Biol Chem. 1999;274(31):21885-92. Published 1999 Jul 30. doi:10.1074/jbc.274.31.21885
Citation 5: Beeton C, Pennington MW, Wulff H, et al. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol. 2005;67(4):1369-81. Published 2005 Apr. doi:10.1124/mol.104.008193
Citation 6: Oliveira JS, Fuentes-Silva D, King GF, et al. Development of a rational nomenclature for naming peptide and protein toxins from sea anemones. Toxicon. 2012;60(4):539-50. Published 2012 Sep 15. doi:10.1016/j.toxicon.2012.05.020
Citation 7: Kim CH, Lee YJ, Go HJ, et al. Defensin-neurotoxin dyad in a basally branching metazoan sea anemone. FEBS J. 2017;284(19):3320-3338. Published 2017 Oct. doi:10.1111/febs.14194
Citation 8: Chi V, Pennington MW, Norton RS, et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 2012;59(4):529-46. Published 2012 Mar 15. doi:10.1016/j.toxicon.2011.07.016
Citation 9: Prentis PJ, Pavasovic A, Norton RS, et al. Sea Anemones: Quiet Achievers in the Field of Peptide Toxins. Toxins (Basel). 2018;10(1). Published 2018 Jan 8. doi:10.3390/toxins10010036
Citation 10: Tudor JE, Pallaghy PK, Pennington MW, et al. Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone. Nat Struct Biol. 1996;3(4):317-20. Published 1996 Apr. doi:10.1038/nsb0496-317
Citation 11: Kalman K, Pennington MW, Lanigan MD, et al. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem. 1998;273(49):32697-707. Published 1998 Dec 4. doi:10.1074/jbc.273.49.32697
Citation 12: Pennington MW, Lanigan MD, Kalman K, et al. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin. Biochemistry. 1999;38(44):14549-58. Published 1999 Nov 2. doi:10.1021/bi991282m
Citation 13: Pennington MW, Beeton C, Galea CA, et al. Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes. Mol Pharmacol. 2009;75(4):762-73. Published 2009 Apr. doi:10.1124/mol.108.052704
Citation 14: Dang B, Kubota T, Mandal K, et al. Native chemical ligation at Asx-Cys, Glx-Cys: chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography. J Am Chem Soc. 2013;135(32):11911-9. Published 2013 Aug 14. doi:10.1021/ja4046795
Citation 15: Murray JK, Qian YX, Liu B, et al. Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3. J Med Chem. 2015;58(17):6784-802. Published 2015 Sep 10. doi:10.1021/acs.jmedchem.5b00495
Citation 16: Dang B, Shen R, Kubota T, et al. Inversion of the Side-Chain Stereochemistry of Indvidual Thr or Ile Residues in a Protein Molecule: Impact on the Folding, Stability, and Structure of the ShK Toxin. Angew Chem Int Ed Engl. 2017;56(12):3324-3328. Published 2017 Mar 13. doi:10.1002/anie.201612398